Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

NCT03531957 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: ASN002
DRUG: Placebo Oral Tablet

Sponsor

Asana BioSciences